- Home
- GHRS vs PENN Comparison
GHRS vs PENN Comparison
Compare GHRS & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | PENN |
|---|---|---|
| Founded | 2018 | 1972 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | GHRS | PENN |
|---|---|---|
| Price | $23.18 | $15.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $41.38 | $20.83 |
| AVG Volume (30 Days) | 150.4K | ★ 2.7M |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $6,362,900,000.00 |
| Revenue This Year | N/A | $6.85 |
| Revenue Next Year | N/A | $3.83 |
| P/E Ratio | ★ N/A | $68.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.04 | $11.65 |
| 52 Week High | $31.44 | $22.36 |
Technical Indicators
Market Signals| Indicator | GHRS | PENN |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 27.92 |
| Support Level | $19.75 | $14.64 |
| Resistance Level | $25.30 | $15.42 |
| Average True Range (ATR) | 1.29 | 0.61 |
| MACD | -0.50 | -0.11 |
| Stochastic Oscillator | 5.58 | 15.21 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 42 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 81% of total sales in 2025; 19% was from the interactive segment, which includes sports, i-gaming, and media revenue. The retail portfolio generates low-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media asset, theScore, provides access to sports betting/i-gaming technology and clientele, helping it form a leading digital position.